Business Context and Reporting Period
Company: Inspire Medical Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 4, 2024
Reporting Period: Quarter ended September 30, 2024
This filing serves as a notification that the Company issued a press release announcing its financial results for the third quarter of 2024. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The Form 8-K text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the press release (Exhibit 99.1) referenced within the filing but are not embedded in the body of this document.
Material Changes
The filing does not explicitly list material changes versus the prior comparable period. It directs readers to the attached press release for the announcement of financial results for the quarter ended September 30, 2024.
Guidance, Outlook, and Management Commentary
- Investor Relations: The Company announced participation in various meetings with investors and analysts during November and December 2024.
- Materials: Presentation materials for these meetings are furnished as Exhibit 99.2 and are available on the Company's Investor Relations website.
- Legal Disclaimer: Information in Items 2.02 and 7.01, including the press release and presentation materials, is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Important Facts for Investor Verification
- Verify the specific revenue and earnings figures in the press release (Exhibit 99.1) as they are not listed in the 8-K summary text.
- Review the presentation materials (Exhibit 99.2) for updated guidance and strategic outlook discussed in upcoming investor meetings.
- Note that the financial data in the attached exhibits is not legally "filed" for liability purposes under Section 18 of the Exchange Act.